Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SHE:301211)
China flag China · Delayed Price · Currency is CNY
12.81
+0.07 (0.55%)
Feb 4, 2026, 1:35 PM CST

SHE:301211 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
544.62543.211,6941,8581,860105.52
Trading Asset Securities
1,0261,094129.4103.98-240
Cash & Short-Term Investments
1,5701,6371,8241,9621,860345.52
Cash Growth
-2.92%-10.26%-7.05%5.50%438.28%-4.77%
Accounts Receivable
56.6375.5375.08127.47161.05114.21
Other Receivables
5.473.82.661.353.092.11
Receivables
62.179.3377.74128.82164.14116.32
Inventory
122.02137.85173.8114.789.5134.59
Other Current Assets
26.6120.6723.5921.2115.677.23
Total Current Assets
1,7811,8752,0992,2272,129603.65
Property, Plant & Equipment
538.35527.75361.99184.8131.7136.76
Long-Term Investments
9.589.64----
Other Intangible Assets
67.3568.9471.0773.2766.6761.45
Long-Term Deferred Tax Assets
2.22.052.192.391.521.38
Long-Term Deferred Charges
2.521.051.33---
Other Long-Term Assets
0.384.6111.0311.471.24-
Total Assets
2,4012,4892,5472,4992,330803.25
Accounts Payable
92.14116.04117.7182.6236.1336.88
Accrued Expenses
11.9714.9912.9211.648.8613.53
Current Portion of Leases
1.091.591.510.97--
Current Income Taxes Payable
1.733.1314.2718.1412.8421.61
Current Unearned Revenue
12.8811.8715.0169.726.3414.03
Other Current Liabilities
7.8416.7613.7325.8238.8413.04
Total Current Liabilities
127.66164.38175.14208.91103.0199.09
Long-Term Leases
2.013.625.156.43--
Long-Term Unearned Revenue
2.012.042.10.220.280.34
Long-Term Deferred Tax Liabilities
10.518.927.496.74.243.43
Total Liabilities
142.19178.97189.89222.26107.53102.85
Common Stock
417.6288288240240180
Additional Paid-In Capital
1,6271,7571,7571,8051,805463.78
Retained Earnings
214.41265.48312.17232.06178.2656.61
Comprehensive Income & Other
0.38-0.3----
Total Common Equity
2,2592,3102,3572,2772,223700.39
Shareholders' Equity
2,2592,3102,3572,2772,223700.39
Total Liabilities & Equity
2,4012,4892,5472,4992,330803.25
Total Debt
3.15.226.667.4--
Net Cash (Debt)
1,5671,6321,8171,9551,860345.52
Net Cash Growth
-2.79%-10.21%-7.04%5.10%438.28%0.79%
Net Cash Per Share
3.753.934.344.715.971.10
Filing Date Shares Outstanding
417.6417.6417.6417.6417.6313.2
Total Common Shares Outstanding
417.6417.6417.6417.6417.6313.2
Working Capital
1,6531,7101,9242,0182,026504.57
Book Value Per Share
5.415.535.645.455.322.24
Tangible Book Value
2,1922,2412,2862,2032,156638.94
Tangible Book Value Per Share
5.255.375.475.285.162.04
Buildings
-257.27114.69107.54103.3696.62
Machinery
-405.47185.73180.96173.8175.42
Construction In Progress
-53.5228.7751.562.17-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.